Clearmind Medicine (CMND) Total Debt (2021 - 2026)
Clearmind Medicine (CMND) posted quarterly Total Debt of $97801.0 for Q2 2026, up 98.58% year-over-year from $49251.0 in Q2 2025, and down 57.05% quarter-over-quarter from $227684.0 in Q1 2026.
Clearmind Medicine (CMND) Total Debt (2021 - 2026) Analysis & Trends
Clearmind Medicine's Total Debt history runs 6 years deep, the most recent figure standing at $97801.0 for Q2 2026.
- In Q2 2026, Total Debt rose 98.58% year-over-year to $97801.0; the TTM figure through Apr 2026 stood at $97801.0 (up 98.58% YoY), while the FY2025 annual figure was $60232.0, up 23.02% from the prior year.
- Total Debt for Q2 2026 stood at $97801.0, down from $227684.0 in the prior quarter.
- The five-year high for Total Debt was $227684.0 in Q1 2026, with the low at $41591.0 in Q3 2023.
- The 5-year median for Total Debt is $49535.5 (2025), against an average of $88025.8.
- The sharpest annual moves came in 2022 and 2023: Total Debt jumped 3129.66% in 2022, then slumped 80.0% in 2023.
- Clearmind Medicine's Total Debt stood at $212199.1 in 2022, then plunged by 80.0% to $42433.0 in 2023, then rose by 15.39% to $48962.0 in 2024, then rose by 23.02% to $60232.0 in 2025, then jumped by 62.37% to $97801.0 in 2026.
- Business Quant data shows CMND's Total Debt at $97801.0 in Q2 2026, $227684.0 in Q1 2026, and $60232.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 9.34 Bn |
| 10 | Clearmind Medicine | 540,485.35 | -13.05 Mn | - | 405,315.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 97,801.00 |
| Jan 31, 2026 | 227,684.00 |
| Oct 31, 2025 | 60,232.00 |
| Jul 31, 2025 | 49,820.00 |
| Apr 30, 2025 | 49,251.00 |
| Jan 31, 2025 | 48,066.00 |
| Oct 31, 2024 | 48,962.00 |
| Jul 31, 2024 | 48,577.00 |
| Apr 30, 2024 | 47,009.00 |
| Jan 31, 2024 | 152,100.00 |
| Oct 31, 2023 | 42,433.00 |
| Jul 31, 2023 | 41,591.00 |
| Jan 31, 2023 | 106,636.24 |
| Oct 31, 2022 | 212,199.06 |
| Oct 31, 2021 | 6,570.32 |